Clinical Trial Update: Viral Infections in Healthy and Immunocompromised Hosts

View source ↗

Summary

An NIAID-sponsored clinical trial is examining viral infections in healthy and immunocompromised hosts. It is currently recruiting and focuses on Anogenital Her…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Herpes
• Herpes Labialis

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Anogenital Herpes, COVID-19 | Status: RECRUITING